Healthcare Research Industry Reports

Single-Use Bioprocessing Market worth $34.9 billion by 2029 📈 Download PDF Brochure:-https://lnkd.in/dSwz77z5 The global single-use bioprocessing market, valued at $17.7 billion in 2024, is projected to reach $34.9 billion by 2029 🌍, with a CAGR of 14.5% 📊. Global Single-Use Bioprocessing Market Dynamics 💡 -DRIVER: Increased productivity & reduced risk of cross contamination ✅ -RESTRAINT: Issues related to leachables & extractives ⚠️ -OPPORTUNITY: Untapped market potential in emerging economies 🌱 -CHALLENGE: Lack of standardization of single-use designs 🔧 The global single-use bioprocessing market is segmented into six major regions 🌎 — North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America was the largest segment in 2023, followed by Europe and the Asia Pacific 🌐. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Sartorius Danaher Corporation  Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany  Avantor, 3Mcompany  Repligen Corporation  Entegris  Getinge Parker Hannifin  ALFA LAVAL CORPORATE AB  Saint-Gobain  Eppendorf Corning Incorporated  Eaton Mettler-Toledo International, Inc Porvair plc  Lonza  ABEC.  PBS Biotech.  Sentinel Process Systems, Inc. Meissner SATAKE MULTIMIX (M) Hamilton Company  Membrane Solutions  COLE-PARMER INSTRUMENT COMPANY LIMITED Distek, Inc.  Esco Lifesciences Group TECNIC Bioprocess Solutions #singleusetechnology #bioprocessing #biotechinnovation #biomanufacturing #pharmamanufacturing

Exosome Diagnostics and Therapeutics Market worth $6,848 million by 2032 Download PDF Brochure:-https://lnkd.in/d633pFcc The report "Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032", is projected to grow from USD 59 million in 2024 to USD 6,848 million by 2032 at a CAGR of 108.9%. Exosome Diagnostics And Therapeutics Market Dynamics -DRIVER: Increasing initiatives for product commercialization -RESTRAINT: Technical complexities associated with exosome isolation -OPPORTUNITY: Growing adoption of exosome biomarkers for personalized medicine -CHALLENGE: Inadequate protocols for exosome development & production North America dominates the global exosome diagnostics and therapeutics market throughout the forecast period. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bio-Techne NanoFCM System Biosciences. Capital Biosciences, AMSBIO INOVIQ Ltd (ASX:IIQ) Direct Biologics Regeneus Ltd Curexsys GmbH i.L. Aegle Therapeutics Mercy BioAnalytics, Inc. multimmune GmbH Rion Exogenus Therapeutics EVerZom Kimera Labs Inc NanoSomix, Inc. Exonox Biosciences, Inc. 胞泌體生技, Capricor Therapeutics, Inc. Evox Therapeutics Ltd ILIAS Biologics Inc. #exosomediagnostics #exosometherapeutics #liquidbiopsy #precisionmedicine #exosomeresearch

Medical Waste Management Market worth $12.2 billion by 2028 Download PDF Brochure: https://lnkd.in/dZsmBmYu Medical waste management market is projected to reach USD 12.2 billion by 2028 from USD 9.2 billion in 2023, at the CAGR of 5.9%. Medical Waste Management Market Dynamics -DRIVER: Increasing volume of healthcare waste -RESTRAINT: High capital investment -OPPORTUNITY: Increasing number of awareness programs for medical waste management in developed countries -CHALLENGE: Lack of awareness about medical waste management in developing countries North America is the largest regional market for medical waste management industry 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 VEOLIA ENVIRONNEMENT-VE Clean Harbors, Stericycle. Waste Management Inc., Cleanaway Waste Management Casella Waste Systems, Inc. Sharps Compliance Inc of Texas, Covanta Hazardous Waste Experts REMONDIS Gruppe BioMedical Waste Solutions, LLC EcoMed Services GRP & ASSOCIATES, MedPro Disposal GIC MEDICAL UK LTD Gamma Waste Systems Triumvirate Environmental All Medical Waste Australia Pty Ltd. Pro Disposal SC SSO Medical Waste Management Safeguard Medical MedWaste Industries LLC #medicalwaste #wastemanagement #healthcarewaste #biohazardwaste #sustainablehealthcare

Bio Decontamination Market worth $339 million by 2028 Download PDF Brochure:-https://lnkd.in/dYcsahRy The global bio decontamination market in terms of revenue was estimated to be worth $238 million in 2023 and is poised to reach $339 million by 2028, growing at a CAGR of 7.3% from 2023 to 2028. Bio Decontamination Dynamics -DRIVER: Rising growth in pharmaceutical & biotechnology industries -OPPORTUNITY: Growing healthcare sector and increasing outsourcing in emerging economies -CHALLENGE: Variability of pathogen-resistance Japan dominates the Asia Pacific bio decontamination market 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 STERIS Ecolab TOMI Environmental Solutions, Inc., JCE BIOTECHNOLOGY Fedegari Group Zhejiang Huahai Pharmaceutical Co., Ltd Howorth Air Tech Solidfog Technologies, SRL ClorDiSys Solutions, Inc AMIRA #biodecontamination #decontamination #infectioncontrol #cleanroomtechnology #sterilization

Stem Cell Assays Market worth $4.5 billion by 2027 Download PDF Brochure:-https://lnkd.in/dk6JThJu The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. Global Stem Cell Assays Market Dynamics -Driver: Increasing funding for stem cell research -Restraint: Issues in embryonic stem cell research -Opportunity: Government initiatives to boost stem cell research -Challenge: Dearth of trained and skilled professionals North America was the largest regional market for Stem cell assays market in 2021. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany Danaher Corporation Becton, Dickinson and Company Bio-Rad Laboratories PerkinElmer Agilent Technologies Promega Corporation CELL BIOLABS, INC. Miltenyi Biotec STEMCELL Technologies Bio-Techne FUJIFILM Holdings Corporation Charles River Laboratories HemoGenix, Inc Lonza Takara Bio Inc. Creative Bioarray AAT Bioquest, BPS Bioscience Inc., Enzo Biochem Inc PromoCell Biotium Geno'Era Technology abcam ReachBio undefined #stemcellassays #stemcellresearch #cellassays #stemcellbiology #stemcelltech

PCR Technologies Market worth $18.3 billion by 2027 Download PDF Brochure:-https://lnkd.in/d9scDMu3 [245 Pages Report] The global market is projected to reach USD 18.3 billion by 2027 from USD 12.5 billion in 2021, at a CAGR of 8.0% during the forecast period. Key highlights: -The Reagents and Consumables segment accounted for the largest share of the PCR technologies market, by product, in 2021 -The qPCR segment accounted for the largest share of the PCR technologies market, by technique, in 2021 -The Diagnostic application segment, by application, accounted for the largest share of the global PCR technologies market in 2021 -On the basis of End Users, Hospitals and Diagnostic Centers segment accounted for the largest share of the global PCR technologies market, in 2021 -The Asia Pacific market is expected to grow at the highest CAGR during the forecast period 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Bio-Rad Laboratories, QIAGEN Takara Bio Inc.. Agilent Technologies, bioMérieux Danaher Corporation Abbott Laboratories - Lafrancol S.A.S Merck Group Becton, Dickinson and Company Promega Corporation Eppendorf Analytik Jena #pcr #polymerasechainreaction #qpcr #realtimepcr #pcrtechnologies

Unleashing the Power of Genomics: Market Set to Revolutionize Healthcare Download PDF Brochure:-https://lnkd.in/d-c84eV2 The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Bio-Rad Laboratories, Eurofins Scientific Finland Oy PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio Inc. BGI Group Eppendorf Merck KGaA, Darmstadt, Germany New England Biolabs Promega Corporation Creative Biogene Novogene., 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. #genomics #genomicresearch #nextgensequencing #precisionmedicine #genomicdata

Dental Bone Graft Substitutes Market worth $1.8 billion in 2029 Download PDF Brochure:-https://lnkd.in/d5zwVtnW The size of global dental bone graft substitute market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029. Dental Bone Graft Substitute Dynamics Driver: Rising aging population Restraint: Stringent regulatory guidelines for medical devices. Opportunity: Growing Prevalence of Dental Disorders 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Dentsply Sirona Envista Holdings Corporation  Johnson & Johnson Stryker Medtronic, Institut Straumann AG  ZimVie.  Henry Schein.  RTI Surgical Holdings, Inc LifeNet Health  Dentium Co., Ltd. Geistlich Pharma Integra LifeSciences Holdings SAS Tissue Regenix Group  Hexin Kuraray Micro Fiber Leather(Jiaxing) Co., Ltd. BeGo Young Innovations, Inc.  Keystone Dental Group   NovaBone Collagen Solutions Osteogenics Biomedical, Inc.  Meyer-Haake GmbH Arora Group #dentalbonegraft #boneregeneration #dentalimplants #oralsurgery #periodontics

Organ Preservation Market worth $317 million by 2026 Download PDF Brochure:-https://lnkd.in/gExU49aE The size of global organ preservation market in terms of revenue was estimated to be worth $230 million in 2021 and is poised to reach $317 million by 2026, growing at a CAGR of 6.6% 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Paragonix Technologies, Inc. XVIVO Dr. Franz Köhler Chemie GmbH Essential Pharmaceuticals, LLC TransMedics, Inc. OrganOx 21st Century Medicine Shanghai Genext Medical Technology Co., Ltd Bridge to Life Ltd. Waters Medical Systems, LLC (an IGL company) Preservation Solutions Inc. Transplant Biomedicals INSTITUT GEORGES V Global Transplant Solutions AVIONORD Organ Preservation Solutions LTD EBERS Biochefarm S.A. Vascular Perfusion Solutions, Inc. TX Innovations #organpreservation #transplantmedicine #organdonation #transplanttechnology #preservationsolutions

Healthcare Provider Network Management Market worth $5.8 billion Download PDF Brochure:-https://lnkd.in/gBGnG-fZ The global healthcare provider network management market in terms of revenue was estimated to be worth $2.9 billion in 20XX and is poised to reach $5.8 billion by 20XX, growing at a CAGR of 14.9% 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Cognizant Change Healthcare Optum Genpact Infosys BPM Atos Syntel, Mphasis, SKYGEN Evolent Osp Labs HGS - Hinduja Global Solutions Virtusa. EXL Vee Technologies symplr Appian Corporation Inovalon Wipro Virsys12, #providernetworkmanagement #healthcarenetworks #healthcaremanagement #healthcareit #networkoptimization